Literature DB >> 8064516

Further studies on the sporozoite transmission of the Salvador I strain of Plasmodium vivax.

W E Collins1, C L Morris, B B Richardson, J S Sullivan, G G Galland.   

Abstract

Different species of Saimiri and Aotus monkeys were inoculated with sporozoites of the Salvador I strain of Plasmodium vivax. Of 58 Saimiri inoculated, 45 developed parasitemia (4 following bites and 41 following intravenous inoculation). Prepatent periods ranged from 10 to 63 days. Twelve of 19 monkeys inoculated with sporozoites that had been stored frozen developed patent parasitemia after 16-53 days. Of 41 Aotus monkeys inoculated, only 10 (2 via bites and 8 via intravenous inoculation) developed parasitemia. One of 7 Aotus inoculated with sporozoites that had been frozen developed parasitemia with a prepatent period of 26 days. Mosquitoes were infected by feeding on gametocytes from Aotus and Saimiri monkeys, chimpanzees, and a human. Sporozoites from Anopheles stephensi, Anopheles freeborni, Anopheles dirus, and Anopheles gambiae induced infection.

Entities:  

Mesh:

Year:  1994        PMID: 8064516

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  3 in total

1.  Experimental evaluation of cryopreservative solutions to maintain in vitro and in vivo infectivity of P. berghei sporozoites.

Authors:  Naresh Singh; Samantha J Barnes; Sandra Kennedy; John H Adams
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

Review 2.  Parasite-Host Interaction and Pathophysiology Studies of the Human Relapsing Malarias Plasmodium vivax and Plasmodium ovale Infections in Non-Human Primates.

Authors:  Erica M Pasini; Clemens H M Kocken
Journal:  Front Cell Infect Microbiol       Date:  2021-02-17       Impact factor: 5.293

3.  Long-term in vitro culture of Plasmodium vivax isolates from Madagascar maintained in Saimiri boliviensis blood.

Authors:  Rajeev K Mehlotra; D'Arbra Blankenship; Rosalind E Howes; Tovonahary A Rakotomanga; Brune Ramiranirina; Stephanie Ramboarina; Thierry Franchard; Marlin H Linger; Melinda Zikursh-Blood; Arsène C Ratsimbasoa; Peter A Zimmerman; Brian T Grimberg
Journal:  Malar J       Date:  2017-11-03       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.